Telehealth Fraud Statistics: What Takedowns, Audits and Remote Patient Monitoring Growth Measure

Telehealth fraud statistics show billions in alleged claims, unusual billing patterns and rapidly growing monitoring payments. If you work inside a telehealth company, laboratory or monitoring business, the useful question is what sits behind the number: a patient encounter, a purchased order, a submitted claim or money actually paid.

False claims take money from Medicare and Medicaid for care patients never received. Those transactions can belong to different businesses. A telemedicine practitioner can sign an order that produces a laboratory or equipment claim elsewhere. Counting only the practitioner’s visit misses the money that the order sets in motion.

What National Telehealth Fraud Takedowns Measure

The Justice Department’s criminal charging announcements repeatedly describe telemedicine orders feeding laboratory and durable medical equipment claims. The money follows the order into the supplier’s bill.

Brace Yourself and Double Helix

Operation Brace Yourself, announced April 9, 2019, alleged over $1.2 billion in losses in schemes involving participants associated with five telemedicine companies. The September 27, 2019 Double Helix action alleged over $2.1 billion in genetic-testing billings. The alleged scheme used telemedicine orders to generate laboratory bills.

Rubber Stamp and the Later Operations

The September 30, 2020 national action, which included Operation Rubber Stamp, alleged over $6 billion in claims. Its telemedicine cases accounted for $4.5 billion of that amount.

Telemedicine cases in the September 17, 2021 action involved over $1.1 billion in alleged claims, while the July 20, 2022 action described more than $1 billion in telemedicine intended losses. The June 28, 2023 action alleged over $2 billion in telemedicine claims, followed by over $1.1 billion in telemedicine-related Medicare claims in the June 27, 2024 action.

The Latest National Actions

The June 30, 2025 announcement alleged over $14.6 billion in intended loss across the whole action. Its combined telemedicine and genetic-testing category involved over $1.17 billion in allegedly fraudulent Medicare claims. The June 23, 2026 announcement described over $6.5 billion in alleged false claims across health care fraud and opioid-abuse schemes, without a standalone telemedicine subtotal.

What the Inspector General’s High-Risk Provider Screen Found

The HHS Office of Inspector General’s September 2022 screen identified providers whose telehealth billing warranted investigation. It examined Medicare fee-for-service claims and Medicare Advantage encounter data from March 1, 2020, through February 28, 2021.

The flagged providers billed for about half a million beneficiaries and received $127.7 million in fee-for-service payments. The Inspector General looked for patterns such as always billing the highest service level, unusually many service days, the same service billed to both Medicare programs, and equipment orders for a high proportion of telehealth beneficiaries. Other measures covered billing both a service and a facility fee for most visits, unusually long visits and unusually many beneficiaries.

The billing also clustered within practices: 991 flagged providers shared a medical practice with at least one other flagged provider. The Inspector General said this may indicate that some practices encouraged the billing.

Company identity was another obstacle. The Inspector General could not systematically identify telehealth companies in the Medicare data. An insider who knows which business controls the billing can supply a connection that the claims alone leave unclear.

Why the Telehealth Audits Give Different Answers

The Inspector General’s 2018 and 2024 audits examined different claims under different rules. The 2018 audit examined claims from 2014 and 2015. Its sampling pool contained 191,118 paid claims from distant practitioners without corresponding claims from the sites where patients received care. That missing counterpart was the reason those claims received attention.

Of 100 sampled claims, 31 failed Medicare requirements. The findings largely concerned where patients received services, especially nonrural sites. Others involved ineligible institutional providers or unauthorized patient sites. At the time, Medicare’s telehealth benefit depended on narrower patient-location requirements.

The February 2024 audit examined evaluation and management services from March through November 2020, after access expanded. Its sampling pool contained 19,570,698 claim lines. Of 110 sampled services, 105 met the requirements reviewed and five lacked adequate documentation. That audit did not review medical necessity or whether practitioners billed the correct visit level.

For someone working in billing, the distinction is practical. A location restriction, an unsupported visit level and an appointment that never happened call for different evidence.

What Remote Patient Monitoring Growth Measures

Medicare’s remote patient monitoring payments rose from $15 million in 2019 to $536 million in 2024, according to the Inspector General’s monitoring oversight report and later billing snapshot. The number of enrollees receiving monitoring rose from about 55,000 to nearly one million over that period. The figures cover patient education and device setup, connected-device readings and treatment management.

The Missing-Component Figure

The Inspector General’s 2024 report found that approximately 244,000 enrollees, or 43% of those receiving monitoring in 2022, lacked a claim or encounter record for at least one component. About 28% lacked a billed education-and-setup component, 23% lacked a billed device-supply component and 12% lacked a billed treatment-management component (the groups overlap).

The Centers for Medicare & Medicaid Services did not require providers to bill all three components. Still, the absence of management claims raises a concrete question: who used the readings to care for the patient? The Inspector General questioned the benefit and necessity of monitoring patients who never received treatment management.

That is where a monitoring employee’s knowledge matters. Device transmissions and records of clinical work can show what happened between enrollment and the recurring claim. A spending curve cannot show whether anybody reviewed a particular patient’s readings.

What an Insider Can Add to the Numbers

An insider can connect a suspicious total to the service, the claim and the decisions that produced it. Individual civil cases show what that connection looks like.

Health Wealth Safe’s settlement concerned alleged Medicare billing for monitoring with devices that did not automatically transmit readings to the company. At Aptihealth, the company’s admissions connected Medicare and Medicaid claims to missed appointments.

Patient recruitment introduces another unit: the lead sold to a supplier. A whistleblower’s complaint describing Empire Pain Center‘s call-center business alleged:

The alleged response to being sold a useless patient lead was a discount on the next order. Someone inside the sales operation can explain who bought the leads and what happened after the sale.

Our experts assess the business behind the billing with you, so the case starts with what you know happened. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

The Billing You Can Explain

If you know why claims keep arriving for visits, orders or monitoring that the business cannot support, talk with our whistleblower experts about what you are seeing. We build the case around your knowledge, bring in healthcare fraud whistleblower lawyers who understand remote-care billing and stay beside you through the case.